The lawsuit claimed J&J marketed Infants’ Tylenol as uniquely formulated for infants when it was actually the same concentration as Children’s Tylenol.
To settle the case, J&J denies any wrongdoing but agreed to pay up to $6.3 million to customers, according to ABC 7.
Those with proof of purchase can file a claim to receive $2.15 for every 1-fluid ounce or 2-fluid ounce bottle purchased between October 2014 and Jan. 6, 2020. Those without proof of purchase can still file a claim, but only for a maximum of seven bottles, or a total of $15.05.
The deadline to file a claim is April 13.
Read the full article here.
More articles on pharmacy:
Bristol-Myers, Sanofi sue Hawaii, accused of violating their free speech
California governor to announce state-run generic drug company
23andMe licenses 1st drug
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.